These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8109947)

  • 1. Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.
    Sumita Y; Fukasawa M
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2743-6. PubMed ID: 8109947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S
    Antimicrob Agents Chemother; 1995 Mar; 39(3):645-9. PubMed ID: 7793866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.
    Fukuoka T; Ohya S; Narita T; Katsuta M; Iijima M; Masuda N; Yasuda H; Trias J; Nikaido H
    Antimicrob Agents Chemother; 1993 Feb; 37(2):322-7. PubMed ID: 8452364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.
    Fung-Tomc JC; Gradelski E; Kolek B; Minassian B; Pucci M; Kessler RE; Bonner DP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):386-93. PubMed ID: 7726503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem.
    Hazumi N; Fuse A; Matsuda K; Hashizume T; Sanada M
    Antimicrob Agents Chemother; 1995 Mar; 39(3):702-6. PubMed ID: 7793876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa.
    Ikonomidis A; Tsakris A; Kantzanou M; Spanakis N; Maniatis AN; Pournaras S
    FEMS Microbiol Lett; 2008 Feb; 279(1):36-9. PubMed ID: 18070070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system.
    Eguchi K; Ueda Y; Kanazawa K; Sunagawa M; Gotoh N
    J Antibiot (Tokyo); 2007 Feb; 60(2):129-35. PubMed ID: 17420563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    Shu JC; Kuo AJ; Su LH; Liu TP; Lee MH; Su IN; Wu TL
    J Antimicrob Chemother; 2017 Sep; 72(9):2489-2495. PubMed ID: 28535274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa.
    Dib C; Trias J; Jarlier V
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):979-86. PubMed ID: 8654449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa.
    Hirabayashi A; Kato D; Tomita Y; Iguchi M; Yamada K; Kouyama Y; Morioka H; Tetsuka N; Yagi T
    J Med Microbiol; 2017 Nov; 66(11):1562-1572. PubMed ID: 28984565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    Gotoh N; Nishino T
    J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
    Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
    Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile.
    Pragasam AK; Raghanivedha M; Anandan S; Veeraraghavan B
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():12. PubMed ID: 26911874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa.
    Fung-Tomc JC; Huczko E; Banville J; Ménard M; Kolek B; Gradelski E; Kessler RE; Bonner DP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):394-9. PubMed ID: 7726504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.